BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Quest Pharmaceutical Services Implements InnaPhase's Watson(TM) Laboratory Information Management System


10/19/2005 5:09:49 PM

PHILADELPHIA, Jan. 27 /PRNewswire/ -- InnaPhase Corporation, a leading provider of Laboratory Information Management System (LIMS) solutions for the life sciences industry, today announced that QPS (Quest Pharmaceutical Services), a leading contract research organization headquartered in Newark, Delaware, has successfully validated and implemented Watson(TM) LIMS in their research and development facilities.

Quest Pharmaceutical Services is a GLP-compliant laboratory that supports drug discovery and development. Functioning as a DMPK arm to their sponsors in the pharmaceutical and biotechnology industry, their niche specialties include LC/MS/MS, biomarker, pharmacokinetic and drug metabolism, P450 inhibition/induction assays, autoradiography and general consulting.

Watson LIMS, a solution within the Pharma LIMS(TM) Suite, is specifically designed to support DMPK/Bioanalytical studies in drug development while ensuring regulatory compliance with the FDA's 21 CFR Part 11 guidance on electronic records and signatures. Watson has an established track record of accelerating bioanalysis, sample management and regulatory compliance in pharmaceutical drug development. The Pharma LIMS Suite also includes Newton(TM) LIMS for pharmaceutical development, quality control, stability and environmental monitoring as well as Galileo(TM) LIMS for in-vitro testing.

"Implementing Watson LIMS is an enormous step in the automation of our bioanalytical laboratory," said Ben Chien, Ph.D., President and CEO of QPS. "Watson LIMS enables us to seamlessly deliver high quality results with unparalleled accuracy to our clients while ultimately increasing our competitive edge within the industry."

"We are particularly happy that Quest has chosen Watson LIMS," said Jo Webber, Ph.D., President and CEO of InnaPhase Corporation. "By automating their drug development processes within their bioanalytical laboratory, Quest will gain a competitive advantage, improve knowledge sharing and enhance their ability to communicate and collaborate with their valued customers."

InnaPhase Corporation provides 18 of the world's top 20 pharmaceutical organizations with its products and services. In addition to the Pharma LIMS Suite, InnaPhase also markets LabManager iLIMS as well as PeakPro Chromatography Data Systems. InnaPhase has locations in the United States, the United Kingdom and distribution centers in India and Japan. For more information, see InnaPhase on the worldwide web at http://www.innaphase.com/.

InnaPhase Corporation

CONTACT: Karen Horan, InnaPhase Corporation, +1-215-964-6055,khoran@innaphase.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES